MMP1 and breast cancer: Our results showed that treatment of cancer cells with celecoxib and miR-101-3p inhibitor reduces COX-2 and MMP1 protein expression as well transmigration of BC cells through the brain endothelium compared to cells treated with miR-101-3p inhibitor alone (Figure 3F,G).